Skip to main content
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED logo

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · MVP ISIN · AU000000MVP2 LEI · 9845007EAECAOD1U4493 ASX Manufacturing
Open in API
Filings indexed 908 across all filing types
Latest filing 2021-05-13 Director's Dealing
Country AU Australia
Listing ASX MVP

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

https://medicaldev.com

Medical Developments International Limited specializes in the development and distribution of emergency pain relief and respiratory products. The company's flagship product is Penthrox, a handheld, self-administered inhaler providing rapid-onset, non-opioid analgesia using methoxyflurane. Penthrox is utilized globally by emergency medical services, hospitals, and for procedural pain in various clinical settings. Additionally, the company manufactures a range of respiratory medical devices, including anti-static spacers and asthma management tools designed to optimize medication delivery. The organization focuses on providing portable, effective solutions for acute pain management and respiratory care, catering to healthcare professionals and patients in emergency, surgical, and primary care environments.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 2 pages 155.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's acquisition of shares, including the number of shares held before and after the transaction, the nature of the interest, and the date of change. The document is a formal notification of a director's personal share transactions. It does not contain financial statements, management discussion, or other report content. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 3242 characters, which is consistent with a notice rather than a full report. Therefore, the correct classification is DIRS.
2021-05-13 English
Appointment of Non Executive Director - Richard Betts 2 pages 191.4KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 11 May 2021 regarding the appointment of Mr. Richard Betts as a Non-Executive Director of Medical Developments International Limited. It details his background, qualifications, and the company's statement welcoming him to the board. There is no financial data, no mention of a report or meeting, no voting results, no legal proceedings, no capital changes, and no other financial or regulatory disclosures. The content clearly fits the category of announcing a change in the company's board of directors. The document length is 3189 characters, which is relatively short and consistent with a typical board/management change announcement. Therefore, the appropriate classification is Board/Management Information (MANG).
2021-05-10 English
Initial Director's Interest Notice 2 pages 125.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities and contracts, including appointment date and shareholdings. This type of document is a report of personal share transactions or interests by company directors. It is not a financial report, management announcement, or regulatory filing unrelated to director dealings. Therefore, it fits the category of Director's Dealing (DIRS). The document length is short but contains substantive information about director interests, not just an announcement or certification.
2021-05-10 English
Proposed issue of Securities - MVP 5 pages 27.4KB
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a proposed issue of securities by Medical Developments International Limited. It details the type of securities, number of securities, issue price, and other conditions related to the placement or issue. There is no financial data, management discussion, or detailed report content. The document is a regulatory announcement about capital raising activities, specifically a placement or other type of issue of securities. This fits the category of Capital/Financing Update (CAP). The document length and content confirm it is not a brief notice or a report publication announcement but a substantive announcement about financing.
2021-03-31 English
Change of Director's Interest Notice 2 pages 154.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's acquisition of shares, including the number of shares held before and after the transaction, the date of change, and the nature of the transaction (on-market purchase). This is a clear report of a personal share transaction by a company director. The document length is 3216 characters, which is consistent with a detailed director's dealing notice rather than a full financial report or announcement. Therefore, the document fits the definition of 'Director's Dealing' (DIRS).
2021-03-25 English
Change of Director's Interest Notice 2 pages 155.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details a director's acquisition of shares, including the number of shares acquired, the nature of the interest, and the date of the transaction. There is no financial performance data, earnings information, or report publication. The content is focused on a director's personal share transactions, which aligns with the definition of 'Director's Dealing' filings. The document length is 3341 characters, which is consistent with a notice rather than a full report. Therefore, the appropriate classification is 'DIRS' for Director's Dealing.
2021-03-08 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.